Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What CAGR And Valuation Are Anticipated For The Knee Bursitis Market?

Over the past few years, the market size for knee bursitis has seen substantial growth. It is expected to escalate from $2.66 billion in 2024 to $2.86 billion in 2025, recording a compound annual growth rate (CAGR) of 7.3%. The historical progress of the market is credited to factors such as an aging demographic, heightened involvement in sports and physical activities, advancements in diagnostic techniques, better availability of healthcare services, and educational initiatives for both healthcare professionals and patients.

The knee bursitis market is projected to witness robust growth in the coming years, escalating to a valuation of $3.72 billion in 2029, growing at a Compound Annual Growth Rate (CAGR) of 6.8%. The surge in the estimated period can be ascribed to the expansion of awareness programs focused on prevention and management, elevation in disposable income, augmentation in healthcare expenditure, and a heightened consciousness and diagnosis of knee bursitis. Key trends anticipated during the forecast period consist of advancements in diagnostic techniques, the inception of innovative therapies, advancements in R&D activities, and the integration of telemedicine and remote monitoring.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16460&type=smp

What Are The Primary Factors Supporting The Knee Bursitis Market Expansion?

The rise in instances of diseases related to bone health is anticipated to spur the expansion of the knee bursitis market in the future. Conditions like arthritis, osteoporosis, and bone cancer, which impact the structure, strength, and function of the bones, fall under bone-related diseases. The growth in such disorders can be credited to elements like an aging populace, inactive lifestyles, substandard nutrition, and changes in the environment. Diseases linked to bones, such as osteoarthritis and rheumatoid arthritis, can trigger knee bursitis by causing inflammation and too much pressure on the knee bursa, leading to pain, swelling, and decreased joint functionality. To illustrate, a September 2022 report by Healthy Bones Australia, a non-profit organization based in Australia, implied that Australia is projected to have 6.2 million individuals of age 50 or more suffering from osteoporosis or osteopenia in 2022. This projection is based on the fact that 22% have osteoporosis and 78% have osteopenia among the 4.74 million Australians with poor bone health. Consequently, the rising occurrence of bone-related issues is fueling the growth of the knee bursitis market.

Which Segments Define The Structure Of The Knee Bursitis Market?

The knee bursitismarket covered in this report is segmented –

1) By Diagnosis: Imaging Test; Other Diagnosis Tests

2) By Treatment: Medication; Therapy; Surgery; Other Treatments

3) By End User: Hospitals And Clinics; Diagnostic Centers; Research Centers; Academic Institutes; Other End Users

Subsegments:

1) By Imaging Test: X-Ray; MRI (Magnetic Resonance Imaging); Ultrasound

2) By Other Diagnosis Tests: Physical Examination; Aspiration Of Joint Fluid; Blood Tests

Who Are The Primary Market Leaders In The Knee Bursitis Market?

Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc, Bayer AG, Novartis AG, Roche Holding AG, Medtronic plc, Eli Lilly and Company, Amgen Inc, Gilead Sciences Inc., Stryker Corporation, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., DePuy Synthes Inc., Arthrex Inc., Globus Medical Inc., Bioventus LLC, Exactech Inc., Genentech Inc., Conformis Inc., Oncolys BioPharma Inc, Bellicum Pharmaceuticals Inc, Merrimack Pharmaceuticals Inc, 4Med Medical Solutions Inc

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

What Regional Factors Are Accelerating Growth In The Knee Bursitis Market?

North America was the largest region in the knee bursitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=16460&type=smp

Browse Through More Reports Similar to the Global Knee Bursitis Market 2025, By The Business Research Company

Knee Implants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/knee-implants-global-market-report

Total Hip And Knee Replacements Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/total-hip-and-knee-replacements-global-market-report

Healthcare Reimbursement Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/healthcare-reimbursement-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model